Suchergebnisse - "Chatterjee, Deep Rohan"

PubPharm (7)

1

Mechanistic Investigation of Thiazole-Based Pyruvate Kinase M2 Inhibitor Causing Tumor Regression in Triple-Negative Breast Cancer

enthalten in: Journal of medicinal chemistry | 2024

von Das, R. | Pulugu, P. | Singh, A. | +7

2

Comprehensive characterization and preclinical assessment of an imidazopyridine-based anticancer lead molecule

enthalten in: Drug development research | 2024

von Bulbule, R. | Jadav, T. | Rajput, N. | +4

3

Comprehensive characterization and preclinical assessment of an imidazopyridine‐based anticancer lead molecule

enthalten in: Drug Development Research | 2024

von Bulbule, R. | Jadav, T. | Rajput, N. | +4

4

Roadmap to Pyruvate Kinase M2 Modulation - A Computational Chronicle

enthalten in: Current drug targets | 2023

von Kapoor, S. | Chatterjee, D. | Chowdhury, M. | +2

5

PROTACting the kinome with covalent warheads

enthalten in: Drug discovery today | 2023

von Chatterjee, D. | Kapoor, S. | Jain, M. | +3

6

The Rise and Fall of Hydroxychloroquine (HCQ) in COVID Era: A Therapeutic Journey and Synthetic Progress

enthalten in: chemRxiv.org | 2022

von Kumar, D. | Nikhil Vaidya, G. | Venkatesh, A. | +6

7

Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions

enthalten in: European journal of medicinal chemistry | 2021

von Vaidya, G. | Rana, P. | Venkatesh, A. | +6

1
[1]